Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H De The

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
British Journal of Haematology|November 5, 1997
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international studyA Bazarbachi, V Soriano, R Pawson, et al.
Experimental Cell Research|December 15, 1996
The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenicC Andre, M C Guillemin, J Zhu, et al.
Blood|May 1, 1997
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cellsG Q Chen, X G Shi, W Tang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
British Journal of Haematology|November 5, 1997
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international studyA Bazarbachi, V Soriano, R Pawson, et al.
Experimental Cell Research|December 15, 1996
The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenicC Andre, M C Guillemin, J Zhu, et al.
Blood|May 1, 1997
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cellsG Q Chen, X G Shi, W Tang, et al.
Pageof 2